(A) In patients with diagnoses of hypertension and/or recorded raised blood pressure
|
No diuretics
| | | | | |
β blockade | 908 | 858 | 1.06 | 0.96 to 1.17 | 713 | 785 | 0.90 | 0.82 to 1.00 |
| | | | p = 0.2 | | | | p = 0.6 |
ACE inhibitors | 600 | 458 | 1.32 | 1.17 to 1.49 | 706 | 496 | 1.44 | 1.28 to 1.61 |
| | | | p<0.0001 | | | | p<0.0001 |
Calcium channel | 765 | 620 | 1.24 | 1.11 to 1.38 | 858 | 672 | 1.29 | 1.16 to 1.42 |
antagonists | | | | p<0.0001 | | | | p<0.0001 |
With diuretics
| | | | | | | | |
β blockade | 1018 | 947 | 1.08 | 0.99 to 1.18 | 326 | 422 | 0.77 | 0.67 to 0.89 |
| | | | p = 0.1 | | | | p<0.0005 |
ACE inhibition | 1031 | 738 | 1.41 | 1.28 to 1.56 | 558 | 390 | 1.44 | 1.26 to 1.64 |
| | | | p<0.0001 | | | | p<0.0001 |
Calcium channel | 1170 | 910 | 1.30 | 1.19 to 1.42 | 562 | 437 | 1.29 | 1.14 to 1.47 |
antagonists | | | | p<0.0001 | | | | p<0.0001 |
(B) In patients without diagnoses of hypertension or recorded raised blood pressure |
No diuretics
| | | | | | | | |
β blockade | 836 | 970 | 0.86 | 0.78 to 0.94 | 472 | 698 | 0.67 | 0.60 to 0.75 |
| | | | p = 0.0015 | | | | p<0.0001 |
ACE inhibitors | 160 | 114 | 1.41 | 1.11 to 1.79 | 166 | 129 | 1.29 | 1.02 to 1.62 |
| | | | p = 0.006 | | | | p = 0.4 |
Calcium channel | 532 | 526 | 1.01 | 0.90 to 1.14 | 468 | 461 | 1.02 | 0.89 to 1.16 |
antagonists | | | | p = 0.9 | | | | p = 0.8 |
With diuretics
| | | | | | | | |
β blockade | 377 | 396 | 0.95 | 0.83 to 1.10 | 168 | 199 | 0.84 | 0.69 to 1.04 |
| | | | p = 0.5 | | | | p = 0.1 |
ACE inhibitors | 303 | 314 | 0.97 | 0.82 to 1.13 | 206 | 214 | 0.96 | 0.79 to 1.17 |
| | | | p = 0.7 | | | | p = 0.7 |
Calcium channel | 512 | 430 | 1.19 | 1.05 to 1.36 | 279 | 257 | 1.09 | 0.92 to 1.29 |
antagonists | | | | p = 0.008 | | | | p = 0.4 |